Grants > Effect of ECM Ligands on RPE Attachment to Bruch's
Updated On: Nov 5, 2025
Macular Degeneration Research Grant
Effect of ECM Ligands on RPE Attachment to Bruch's
Innovative Approaches to Macular Degeneration Treatments
About the Research Project
Program
Macular Degeneration Research
Award Type
Standard
Award Amount
$50,000
Active Dates
April 01, 1999 - March 31, 2000
Grant ID
M1999018
Goals
Grantee institution at the time of this grant: University of Medicine and Dentistry of New Jersey
Related Grants
Macular Degeneration Research
New Drug Delivery Approach to Transform Macular Degeneration Treatment
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Daisy Shu, PhD
Current Organization
University of New South Wales
New Drug Delivery Approach to Transform Macular Degeneration Treatment
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Daisy Shu, PhD
Current Organization
University of New South Wales
Macular Degeneration Research
A Novel Implantable Device to Treat Wet Macular Degeneration
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Charles DeBoer, MD, PhD
Current Organization
Stanford University
A Novel Implantable Device to Treat Wet Macular Degeneration
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Charles DeBoer, MD, PhD
Current Organization
Stanford University
Macular Degeneration Research
The Development of a Transplant-Independent Therapy for RPE Dysfunction
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Shintaro Shirahama, MD, PhD
Current Organization
Schepens Eye Research Institute of Massachusetts Eye and Ear
The Development of a Transplant-Independent Therapy for RPE Dysfunction
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Shintaro Shirahama, MD, PhD
Current Organization
Schepens Eye Research Institute of Massachusetts Eye and Ear